Numis Securities Ltd restated their add rating on shares of Spire Healthcare Group PLC (LON:SPI) in a research report report published on Thursday morning. They currently have a GBX 350 ($4.52) price objective on the stock.

Several other analysts have also recently issued reports on SPI. Liberum Capital reaffirmed a buy rating and set a GBX 400 ($5.17) target price on shares of Spire Healthcare Group PLC in a research report on Friday, May 26th. Jefferies Group LLC increased their target price on Spire Healthcare Group PLC from GBX 305 ($3.94) to GBX 350 ($4.52) and gave the company a hold rating in a research report on Thursday, June 1st. Berenberg Bank increased their target price on Spire Healthcare Group PLC from GBX 360 ($4.65) to GBX 390 ($5.04) and gave the company a buy rating in a research report on Wednesday, June 21st. Finally, Credit Suisse Group reaffirmed an underperform rating on shares of Spire Healthcare Group PLC in a research report on Friday, July 21st. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company’s stock. The company has a consensus rating of Hold and a consensus target price of GBX 347 ($4.48).

Shares of Spire Healthcare Group PLC (LON SPI) opened at 256.70 on Thursday. The company’s market capitalization is GBX 1.03 billion. Spire Healthcare Group PLC has a 12-month low of GBX 230.40 and a 12-month high of GBX 411.00. The firm has a 50-day moving average price of GBX 327.79 and a 200 day moving average price of GBX 332.90.

Spire Healthcare Group PLC (LON:SPI) last announced its earnings results on Thursday, September 14th. The company reported GBX 8.70 ($0.11) earnings per share (EPS) for the quarter, beating the consensus estimate of GBX 8.60 ($0.11) by GBX 0.10 ($0.00). The business had revenue of £481 million for the quarter. Spire Healthcare Group PLC had a return on equity of 3.47% and a net margin of 3.92%. On average, equities research analysts predict that Spire Healthcare Group PLC will post $18.48 earnings per share for the current year.

ILLEGAL ACTIVITY WARNING: “Spire Healthcare Group PLC’s (SPI) “Add” Rating Reaffirmed at Numis Securities Ltd” was originally reported by The Cerbat Gem and is the property of of The Cerbat Gem. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://www.thecerbatgem.com/2017/09/18/spire-healthcare-group-plcs-spi-add-rating-reaffirmed-at-numis-securities-ltd.html.

The business also recently announced a dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Thursday, November 16th will be given a dividend of GBX 1.30 ($0.02) per share. The ex-dividend date is Thursday, November 16th. This represents a yield of 0.5%.

About Spire Healthcare Group PLC

Spire Healthcare Group plc is a United Kingdom-based independent hospital group. The Company provides in-patient, daycase and out-patient care from approximately 40 hospitals, 10 clinics and over two specialist care centers across the United Kingdom. The Company also owns and operates a sports medicine, physiotherapy and rehabilitation brand, Perform, and a screening service, Lifescan, as well as national pathology services.

Analyst Recommendations for Spire Healthcare Group PLC (LON:SPI)

Receive News & Stock Ratings for Spire Healthcare Group PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Spire Healthcare Group PLC and related stocks with our FREE daily email newsletter.